Vishnevskaia E E, Okeanova N I, Savkova N V
Med Radiol (Mosk). 1989 Feb;34(2):61-6.
The authors described the results of combined radiotherapy of 219 cervical cancer patients, stage TIBN0M0, of them 47 were treated by routine intracavitary gamma-beam therapy including intracavitary irradiation based on the principle of successive administration of low activity radionuclide sources and 134 patients-by that of high activity radionuclide sources. Gamma-beam therapy was of one type. There was no significant difference in 5-year survival rates in patients treated by combined radiotherapy including intracavitary gamma-beam therapy based on the principle of successive administration of low or high activity radionuclides. However, the survival rate in them as compared to that in patients treated by intracavitary irradiation of common type, was much higher. Rectal complications were most frequent in patients treated by routine radiotherapy, bladder complications were noted in patients treated by successive administration of high activity radionuclide sources.
作者描述了219例TIBN0M0期宫颈癌患者的联合放疗结果,其中47例采用常规腔内伽马射线治疗,包括基于低活度放射性核素源连续给药原则的腔内照射,134例采用高活度放射性核素源的腔内照射。伽马射线治疗为单一类型。在基于低活度或高活度放射性核素连续给药原则的包括腔内伽马射线治疗的联合放疗患者中,5年生存率无显著差异。然而,与普通类型腔内照射治疗的患者相比,他们的生存率要高得多。常规放疗患者直肠并发症最常见,高活度放射性核素源连续给药治疗的患者出现膀胱并发症。